Business Services Industry
Healthscope feels market squeeze as merger prescription gets a dose of pressure.
Australasian Business Intelligence, July, 2007
Byline: Stephen Bartholomeusz
Jul 05, 2007 (The Age - ABIX via COMTEX) -- Healthscope's falling share price could jeopardise its $A1bn scheme-of-arrangement merger with Symbion Health. The cash-and-scrip deal was struck when Healthscope shares were trading at $A5.80. It was conditional on their volume-weighted average price remaining above $A5.30 in the 10 days prior to the scheme meeting, for which no date has yet been set. On 5 July 2007 Healthscope shares closed at $A5.30 and had traded near $A5.20 in the fortnight prior due to concerns that the competition regulator may extract expensive concessions. Hedge funds are seeking to profit from the uncertainty.
Publication Date: 6 July 2007
HEALTHSCOPE LIMITED - ASX HSP
SYMBION HEALTH...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- Design a commission plan that drives sales - Sales Commissions
